VIJOINT - VISCOSUPPLEMENTATION

VIJOINT - VISCOSUPPLEMENTATION
Product Description

Vijoint, provides a linear intermediate (~1,000-1,500 KDa) Molecular Weight Hyaluronic Acid (HA) for intra-articular viscosupplementation. A recent review highlights that:

  • HA preparations with Molecular weight (MW) between 500 and 1,500 KDa can achieve maximum concentration in the joint
  • the intermediate MW HA compounds are superior than those with low MW(2) and equivalent to higher MW ones(1)
EFFICACY IN COUNTERACTING THE QUALITATIVE AND QUANTITATIVE HA DEFICIENCY IN OSTEOARTHRITIS (OA). VIJOINT OFFERS A WIDE RANGE OF HA CONCENTRATIONS AND VOLUMES FOR ALL TYPES OF JOINTS AND PATIENTS.

YOUNG TARGET
 MECHANICAL ACTIVITY
  • restoring viscoelastic properties of synovial fluid
  • shock absorption
  • lubrication
  • reducing stifness
    • CHONDROPROTECTION ACTIVITY
    • preventing cartilage degeneration by oxidative stress inhibition
    • stimulating the endogenous synthesis of HA by synovial fibroblasts
     ELDER TARGET
    ANALGESIC ACTIVITY 
    • reducing the induction of pain mediators
    • interacting with HA receptors on or around the free nerve endings
    ANTI-INFLAMMATORY ACTIVITY
    • suppressing proinflammatory mediators: IL8, IL6,PGE2 TNF
    • inhibiting migration and aggregation of leukocyte and macrophages

    Read more Show less

    Biofarma S.p.A.

    • IT
    • 2015
      On CPHI since
    • 5
      Certificates
    • 500 - 999
      Employees
    Company types
    Manufacturer/Innovator
    View company profile
    Categories
    more categories Show less
    Specifications
    • Supplied from
      Italy
    More specifications Fewer specifications
    Sales Markets
    Show more Show less

    Biofarma S.p.A.

    • IT
    • 2015
      On CPHI since
    • 5
      Certificates
    • 500 - 999
      Employees
    Company types
    Manufacturer/Innovator
    View company profile

    More Products from Biofarma S.p.A. (4)

    • Lenoid

      Product Lenoid

      Hemorrhoidal disease (HD) is one of the most common anorectal benign disorder affecting millions of people around the world. Almost 75% of all adults develop piles at some point in their life. Lenoid™ cream is a medical device indicated for the treatment of hemorrhoidal disease (internal and external hemor...
    • Respecta Balance Gel

      Product Respecta Balance Gel

      Respecta® Balance Gel is a medical device specifically studied for rebalancing the physiological pH and vaginal microbiota that represents an effective adjuvant for the treatment of vaginitis and vaginosis.

      Thanks to the synergistic action of its components:
      • Restores physiological vagina...
    • Gastro Stop

      Product Gastro Stop

      GASTRO STOP is a class IIa medical device, having an anti-reflux action and containing sodium alginate, sodium bicarbonate, sodium carbonateand calcium carbonate.

      PRODUCT

      The product is indicated to reduce gastro-oesophageal reflux diseasesymptoms, including heartburn, gastric pyrosis during ...
    • VIJOINT HCC

      Product VIJOINT HCC

      Vijoint HCC is a patented fixed combination of Hyaluronic Acid (HA) sodium salt 2%, chondroitin-Sulfate 2% (CS) and Hydroxypropyl beta-Cyclodextrin 1%.
      HA AND CS ACT IN SYNERGY TO CONTRAST DISEASE SYMPTOMS AND SLOW DOWN ITS PROGRESSION.

      YOUNG TARGETHYALURONIC A...

    Biofarma S.p.A. resources (1)

    • Biofarma Group Presentation

      Brochure Biofarma Group Presentation

      The CDMO that grows by innovatingBiofarma Group is the new Italian and European market leader in the development, manufacture and packaging of supplements, medical devices, probiotic-based drugs and cosmetics, exclusively for third parties.